A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Thursday, May 25 | 12-1 p.m. ET | Online
The Duke Precision Medicine Program Forum Series features speakers from Duke and beyond working on innovative research in clinical, translational, and basic sciences.
Katherine Collins, PhD
Postdoctoral Associate
Duke Molecular Physiology Institute
Precision Medicine Program T32
Title: Factors predicting who will stick with a lifestyle intervention: Utilizing precision medicine to improve healthy lifestyle behaviors
Learn more and register on the Precision Medicine Forum Series website.
GMKB